Lunch & Learn with Neurology Residents - Myasthenia Gravis

Wednesday, March 5, 2025, 1:00 PM - Sunday, March 5, 2028, 2:00 PM

ANCC Nursing Contact Hours (1.00 hours), General Attendance (1.00 hours)

This education series is intended to address the knowledge gaps surrounding neuro-specific conditions and interventions provided to patients within neuroscience care areas.

Presenter

Mackenzie Bell, DO
Neurology Resident PGY-2
Dartmouth Hitchcock Medical Center

1. Discuss the pathophysiology of Myasthenia Gravis and Myasthenic Crisis.
2. Recognize the clinical signs and symptoms of Myasthenia Gravis.
3. Describe treatment options for Myasthenia Gravis.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 ANCC contact hour. 

All other learners may claim General Attendance credit. Consult your professional licensing board regarding the applicability and acceptance of General Attendance credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Registration/Requirements for Successful Completion

You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.

2. Register for the activity.

3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.

4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).

5. Click the Complete Evaluation button, or click My Account in the menu bar; then click Evaluations.

6. Complete and Submit the Evaluation.

 

Bibliographic Sources

1. Acetylcholinesterase inhibitors for myasthenia gravis. (2018, December 10). Www.youtube.com; Drugs in Motion. https://www.youtube.com/watch?v=-TzclKd2kL0

2. Asghar H, Sheikh FN, Dev H, Lazarevic MB, Hassan SA. An Atypical Presentation of Myasthenia Gravis: A Case Report. Cureus. 2019 Apr 29;11(4):e4563. https://doi.org/10.7759/cureus.4563. PMID: 31281747; PMCID: PMC6599468.

3. Ali Zaman Butt. “Neuromuscular Junction Animation, All 7 Steps of Muscle Contraction in 1 Minute, Full Explanation.” YouTube, 3 Dec. 2022, https://www.youtube.com/watch?v=0C9MNSMf5B8. Accessed 16 Oct. 2024.

4. Claytor, B., Cho, S.-M., & Li, Y. (2023). Myasthenic Crisis. Muscle & Nerve, 68(1), 8–19. https://doi.org/10.1002/mus.27832

5. Estephan EP, Baima JPS, Zambon AA. Myasthenia gravis in clinical practice. Arq Neuropsiquiatr. 2022 May;80(5 Suppl 1):257-265. https://doi.org/10.1590/0004-282X-ANP-2022-S105. PMID: 35976295; PMCID: PMC9491427.

6. Gilhus, N. E. (2016). Myasthenia gravis. New England Journal of Medicine, 375(26), 2570–2581. https://doi.org/10.1056/nejmra1602678

7. Muzio, B. D., & Maia, D. (2019). Thymoma. Radiopaedia.org. https://doi.org/10.53347/rid-67397

8. Narayanaswami, P., Sanders, D. B., Wolfe, G., Benatar, M., Cea, G., Evoli, A., Gilhus, N. E., Illa, I., Kuntz, N. L., Massey, J., Melms, A., Murai, H., Nicolle, M., Palace, J., Richman, D., & Verschuuren, J. (2020). International consensus guidance for management of myasthenia gravis. Neurology, 96(3), 10.1212/WNL.0000000000011124. https://doi.org/10.1212/wnl.0000000000011124

9. Omar A, Marwaha K, Bollu PC. Physiology, Neuromuscular Junction. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-Available from: https://www.ncbi.nlm.nih.gov/books/NBK470413/

10. Remijn-Nelissen, L., Verschuuren, J. J. G. M., & Tannemaat, M. R. (2022). The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study. Neuromuscular Disorders, 32(10). https://doi.org/10.1016/j.nmd.2022.09.002

RESOURCES FOR PROFESSIONALS

1. Myasthenia Gravis Foundation of America. (2024, September 20). Myasthenia Gravis Foundation of America. https://myasthenia.org/professionals/resources-for-professionals/

2. Ursua, E. (2024). Clinical Case Reports International Myasthenia Gravis: A Case Report of a Classical Presentation Clinical Image Clinical Image OPEN ACCESS. https://www.clinicalcasereportsint.com/open-access/myasthenia-gravis-a-case-report-of-a-classical-presentation-9834.pdf

3. Zisimopoulou, P., Brenner, T., Trakas, N., & Tzartos, S. J. (2013). Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens. Autoimmunity Reviews, 12(9), 924–930. https://doi.org/10.1016/j.autrev.2013.03.002

   
   

 

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
ACE Office
Dartmouth Health
[email protected]

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.